Aurora Cannabis Inc. (TSE:ACB - Get Free Report)'s stock price traded down 16% on Wednesday . The company traded as low as C$10.10 and last traded at C$10.62. 1,636,959 shares traded hands during trading, an increase of 14% from the average session volume of 1,431,973 shares. The stock had previously closed at C$12.65.
Analyst Ratings Changes
Several research analysts have recently issued reports on ACB shares. Canaccord Genuity Group upgraded shares of Aurora Cannabis from a "hold" rating to a "buy" rating and set a C$0.80 target price on the stock in a research note on Friday, February 9th. CIBC cut their target price on Aurora Cannabis to C$6.00 and set a "neutral" rating on the stock in a research note on Wednesday, February 21st. Finally, Jefferies Financial Group reduced their target price on Aurora Cannabis from C$6.12 to C$4.95 and set a "hold" rating for the company in a report on Tuesday, February 27th.
Read Our Latest Stock Analysis on Aurora Cannabis
Aurora Cannabis Stock Performance
The business has a 50-day moving average of C$6.60 and a 200 day moving average of C$2.75. The company has a debt-to-equity ratio of 18.51, a current ratio of 3.79 and a quick ratio of 2.48. The company has a market cap of C$552.49 million, a PE ratio of -0.13 and a beta of 2.83.
Aurora Cannabis (TSE:ACB - Get Free Report) last posted its quarterly earnings data on Thursday, February 8th. The company reported C($0.20) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of C($0.10) by C($0.10). Aurora Cannabis had a negative return on equity of 137.28% and a net margin of 151.71%. The business had revenue of C$72.61 million during the quarter, compared to analysts' expectations of C$63.50 million. Equities research analysts anticipate that Aurora Cannabis Inc. will post -0.22 EPS for the current fiscal year.
Aurora Cannabis Company Profile
(
Get Free Report)
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Featured Stories
Before you consider Aurora Cannabis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aurora Cannabis wasn't on the list.
While Aurora Cannabis currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report
